Skip to main navigation
Logo

Live - Corprorate Menu

  • About Us
    • History
    • Our Leadership
    • Collaborations
    • Compliance and Ethics
    • Corporate Giving
  • Our Focus
    • Cerebral Adrenoleukodystrophy
    • Multiple Myeloma
    • Sickle Cell Disease
    • Transfusion Dependant Beta-Thalassemia
  • Our Science
    • What is Gene Therapy?
    • Gene Therapy Techniques
    • Clinical Trials
    • Our Pipeline
  • Our Products
  • Patients & Advocacy
    • Patient Advocacy
    • Patient Resources
    • Access Policy

Live - Top Nav

  • investors & media
  • contact us
  • careers
  • stories

Investors & Media

Overview Corporate Governance Press Releases Events & Presentations Analyst Coverage Stock Information SEC Filings Investor FAQs

Toolkit

  • Annual Meeting
  • Information Request
  • Corporate Presentation
  • Our Value Model
  • Sign Up for Email Alerts
  • RSS Feeds

Media Contacts

  • Jenn Snyder

    VP, Corporate Communications

    (617) 448-0281

    JSnyder@bluebirdbio.com

  • Catherine Falcetti

    Senior Director, Corporate Communications

    (339) 499-9436

    CFalcetti@bluebirdbio.com

Investor Contacts

  • Ingrid Goldberg

    VP, Investor Relations

    (857) 217-0490

    IGoldberg@bluebirdbio.com

  • Elizabeth Pingpank

    Director, Investor Relations

    (617) 914-8736

    EPingpank@bluebirdbio.com

SEC Filing Details

Document Details

Form
8-K/A
Filing Date
Mar 29, 2021
Document Date
Mar 26, 2021
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
bluebird bio, Inc.
Issuer
bluebird bio, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT

Quick Links

  • Patients & Advocacy
  • Investors & Media
  • Careers
  • Contact Us

CONTACT INFO

info@bluebirdbio.com

clinicaltrials@bluebirdbio.com

investor@bluebirdbio.com

medinfo@bluebirdbio.com

Live - Terms & Privacy

  • Terms of Service
  • Privacy Policy
  • Cookie Notice
  • Sitemap
© 2021 bluebird bio, Inc. All Rights Reserved. Corp-GBL-00011 05/19

Live - Social Links